CL, H., BW, T., LJ, Y., ZN, D., H, L., GQ, P., . . . T, L. (2024). The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: A systematic review and meta-analysis. Expert review of anticancer therapy, 24(5), 303. https://doi.org/10.1080/14737140.2024.2341723
Chicago Style (17th ed.) CitationCL, Han, et al. "The Effect of Age, Sex, and Eastern Cooperative Oncology Group Performance Status on the Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis." Expert Review of Anticancer Therapy 24, no. 5 (2024): 303. https://doi.org/10.1080/14737140.2024.2341723.
MLA (9th ed.) CitationCL, Han, et al. "The Effect of Age, Sex, and Eastern Cooperative Oncology Group Performance Status on the Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis." Expert Review of Anticancer Therapy, vol. 24, no. 5, 2024, p. 303, https://doi.org/10.1080/14737140.2024.2341723.
